Key result
Sanguinarine inhibited PCV2 CAP gene expression in infected PK-15 cells by upregulating IFIH1 and suppressing p38α and JNK pathways.
Sanguinarine demonstrates anti-PCV2 effects through multiple targets and pathways, suggesting potential for new veterinary drug development.
Answers are grounded in this paper and cite their sources.
Sanguinarine shows anti-PCV2 activity in vitro; leaves open therapeutic translation pending in vivo swine studies.
Porcine circovirus type 2 (PCV2) is highly prevalent in nature and serves as the primary pathogen responsible for porcine circovirus-associated disease (PCVD/PCVAD), posing a significant threat to pig production. Currently, vaccination alone could not provide the complete protection for PCV2 infection. The active ingredients of traditional Chinese medicine have shown a positive effect in combating viral infections. This study employed tandem mass tag (TMT) labeled proteomic analyses and network pharmacology to examine the effect and mechanism of sanguinarine against PCV2. IFIH1, IFITM1, p38α, and JNK were identified as the key targets of sanguinarine against PCV2 based on proteomics and network pharmacology. Using PCV2-infected PK-15 cells, it was discovered that sanguinarine inhibited the expression of the PCV2 CAP gene by upregulating IFIH1, thereby promoting STAT1 phosphorylation and activating MAVS expression. This, in turn, facilitated IRF3 phosphorylation, leading to increase IFITM1 expression. Simultaneously, sanguinarine suppressed the expression of the PCV2 CAP gene by inhibiting the expression of p38α, JNK, and p-JNK protein. In conclusion, the results of this study suggest that sanguinarine exerts anti-PCV2 effects through different targets and pathways, which lays the foundation for the subsequent development of new anti-PCV2 veterinary drugs.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2025) studied Porcine circovirus type 2 (PCV2) infection. Sanguinarine was evaluated on Inhibition of PCV2 CAP gene expression and identification of key targets. Sanguinarine inhibited PCV2 CAP gene expression in infected PK-15 cells by upregulating IFIH1 and suppressing p38α and JNK pathways.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: